• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁死亡相关基因作为三阴性乳腺癌生存和免疫治疗的预后标志物:公共数据库和单一机构分析

Ferroptosis-related genes as prognostic markers for survival and immunotherapy in triple-negative breast cancer: analysis of public databases and a single institution.

作者信息

Xie Yizhao, Tao Zhonghua, Wang Biyun, Zhao Yannan, Chen Xinyu, Li Bin, Wang Jinyan, Chen Guangliang, Hu Xichun

机构信息

Department of Medical Oncology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

Ther Adv Med Oncol. 2025 Feb 28;17:17588359251322291. doi: 10.1177/17588359251322291. eCollection 2025.

DOI:10.1177/17588359251322291
PMID:40034604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11873862/
Abstract

BACKGROUND

Ferroptosis plays a vital role in cancer development and treatment. The relationship between ferroptosis-related genes and breast cancer prognosis, as well as immunotherapy outcomes, remains unknown.

OBJECTIVES

To evaluate the prognostic value of ferroptosis-related genes in breast cancer.

METHODS

We conducted differential expressions and prognostic analysis for ferroptosis-related genes on public databases and breast cancer patients in our center and analyzed their predictive value for immunotherapy of breast cancer patients.

RESULTS

We identified prognostic ferroptosis-related genes, constructed a nomogram, and validated key genes using patient data from our center. We also investigated ferroptosis-related genes significantly associated with immune infiltration and identified as a promising biomarker for triple-negative breast cancer immunotherapy.

CONCLUSION

Ferroptosis-related genes had potential prognostic value and predictive value for breast cancer immunotherapy.

摘要

背景

铁死亡在癌症的发生发展及治疗中起着至关重要的作用。铁死亡相关基因与乳腺癌预后以及免疫治疗结果之间的关系尚不清楚。

目的

评估铁死亡相关基因在乳腺癌中的预后价值。

方法

我们在公共数据库以及本中心的乳腺癌患者中对铁死亡相关基因进行差异表达和预后分析,并分析它们对乳腺癌患者免疫治疗的预测价值。

结果

我们鉴定出了预后性铁死亡相关基因,构建了列线图,并使用本中心的患者数据验证了关键基因。我们还研究了与免疫浸润显著相关的铁死亡相关基因,并确定其为三阴性乳腺癌免疫治疗的一个有前景的生物标志物。

结论

铁死亡相关基因对乳腺癌免疫治疗具有潜在的预后价值和预测价值。

相似文献

1
Ferroptosis-related genes as prognostic markers for survival and immunotherapy in triple-negative breast cancer: analysis of public databases and a single institution.铁死亡相关基因作为三阴性乳腺癌生存和免疫治疗的预后标志物:公共数据库和单一机构分析
Ther Adv Med Oncol. 2025 Feb 28;17:17588359251322291. doi: 10.1177/17588359251322291. eCollection 2025.
2
Construction of a ferroptosis-based prognostic model for breast cancer helps to discriminate high/low risk groups and treatment priority.构建基于铁死亡的乳腺癌预后模型有助于区分高/低风险组和治疗优先级。
Front Immunol. 2023 Dec 13;14:1264206. doi: 10.3389/fimmu.2023.1264206. eCollection 2023.
3
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.鉴定铁死亡相关基因特征在乳腺癌患者中的预后价值。
BMC Cancer. 2021 May 31;21(1):645. doi: 10.1186/s12885-021-08341-2.
4
Ferroptosis and triple-negative breast cancer: Potential therapeutic targets.铁死亡与三阴性乳腺癌:潜在的治疗靶点。
Front Oncol. 2022 Dec 9;12:1017041. doi: 10.3389/fonc.2022.1017041. eCollection 2022.
5
A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer.一种新型与铁死亡相关的基因预后指标,用于预测前列腺癌患者的预后和免疫治疗反应。
Front Endocrinol (Lausanne). 2022 Aug 10;13:975623. doi: 10.3389/fendo.2022.975623. eCollection 2022.
6
An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer.铁代谢和免疫相关基因特征可预测三阴性乳腺癌的临床结局和分子特征。
BMC Cancer. 2022 Jun 7;22(1):619. doi: 10.1186/s12885-022-09679-x.
7
Comprehensive analysis of the relationship between the ferroptosis and tumor-infiltrating immune cells, mutation, and immunotherapy in breast cancer.乳腺癌中铁死亡与肿瘤浸润免疫细胞、突变及免疫治疗之间关系的综合分析。
Ann Transl Med. 2022 Aug;10(15):833. doi: 10.21037/atm-22-3736.
8
Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.铁死亡调控因子,特别是 SQLE,在乳腺癌的预后、进展和免疫环境中发挥重要作用。
BMC Cancer. 2021 Oct 29;21(1):1160. doi: 10.1186/s12885-021-08892-4.
9
Identification of a PANoptosis-related prognostic model in triple-negative breast cancer, from risk assessment, immunotherapy, to personalized treatment.三阴性乳腺癌中PAN细胞焦亡相关预后模型的鉴定:从风险评估、免疫治疗到个性化治疗
Heliyon. 2024 Sep 30;10(19):e38732. doi: 10.1016/j.heliyon.2024.e38732. eCollection 2024 Oct 15.
10
Exploring a 7-gene prognostic model based on ferroptosis for efficiently guiding immunotherapy in melanoma patients.探索基于铁死亡的 7 基因预后模型,以有效指导黑色素瘤患者的免疫治疗。
Adv Med Sci. 2022 Sep;67(2):364-378. doi: 10.1016/j.advms.2022.09.004. Epub 2022 Sep 22.

本文引用的文献

1
Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors.ARID1A 低表达导致适应性免疫抵抗,并使三阴性乳腺癌对免疫检查点抑制剂敏感。
Cancer Commun (Lond). 2023 Sep;43(9):1003-1026. doi: 10.1002/cac2.12465. Epub 2023 Jul 11.
2
Biology and pharmacology of platelet-type 12-lipoxygenase in platelets, cancer cells, and their crosstalk.血小板、癌细胞及其相互作用中的血小板型 12-脂氧合酶的生物学和药理学。
Biochem Pharmacol. 2022 Nov;205:115252. doi: 10.1016/j.bcp.2022.115252. Epub 2022 Sep 18.
3
ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer.
ALOX12:贝伐单抗反应、免疫治疗效果和结直肠癌预后的新见解。
Front Immunol. 2022 Jun 27;13:910582. doi: 10.3389/fimmu.2022.910582. eCollection 2022.
4
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis.乳腺脂肪细胞保护三阴性乳腺癌细胞免受铁死亡。
J Hematol Oncol. 2022 Jun 3;15(1):72. doi: 10.1186/s13045-022-01297-1.
5
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer.IMpassion131 研究是一项双盲、安慰剂对照、随机 III 期临床试验,旨在评估一线紫杉醇联合或不联合阿替利珠单抗治疗不可切除局部晚期/转移性三阴性乳腺癌的主要结果。
Ann Oncol. 2021 Aug;32(8):994-1004. doi: 10.1016/j.annonc.2021.05.801. Epub 2021 Jul 1.
6
PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer.聚腺苷二磷酸核糖聚合酶抑制剂通过抑制 SLC7A11 促进铁死亡,并与 BRCA 功能正常的卵巢癌中的铁死亡诱导剂协同作用。
Redox Biol. 2021 Jun;42:101928. doi: 10.1016/j.redox.2021.101928. Epub 2021 Mar 5.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Broadening horizons: the role of ferroptosis in cancer.拓宽视野:铁死亡在癌症中的作用。
Nat Rev Clin Oncol. 2021 May;18(5):280-296. doi: 10.1038/s41571-020-00462-0. Epub 2021 Jan 29.
9
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.帕博利珠单抗联合化疗对比安慰剂联合化疗用于治疗既往未经治疗的局部晚期不可切除或转移性三阴性乳腺癌(KEYNOTE-355):一项随机、安慰剂对照、双盲、III 期临床研究。
Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9.
10
Deletion of ferritin H in neurons counteracts the protective effect of melatonin against traumatic brain injury-induced ferroptosis.神经元铁蛋白 H 的缺失抵消了褪黑素对创伤性脑损伤诱导的铁死亡的保护作用。
J Pineal Res. 2021 Mar;70(2):e12704. doi: 10.1111/jpi.12704. Epub 2020 Nov 29.